Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

NCT05878951 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Urinary Incontinence
Overactive Bladder Syndrome
Overactive Bladder
Urologic Diseases

Interventions

DRUG: OnabotulinumtoxinA

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]
[object Object]